Skip to main content
Article thumbnail
Location of Repository

Prognostic indices for brain metastases – usefulness and challenges

By Carsten Nieder and Minesh P Mehta
Topics: Review
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2666747
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
    2. (2008). Altundag K: Characteristics of breast cancer patients with central nervous system metastases: a singlecenter experience.
    3. (1990). B: A randomized trial of surgery in the treatment of single metastases to the brain.
    4. (1998). B: Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA
    5. (2002). Brain metastases from esophageal carcinoma: natural history, prognostic factors, and outcome. Cancer
    6. (2003). Brain metastases in patients with cancer of unknown primary.
    7. (2004). Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome.
    8. (2008). Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res
    9. (1997). Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
    10. (2007). Chiang VL: Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. Cancer
    11. (2004). Curran WJ Jr: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet
    12. (2000). de Oliveira Borges SR, Wajsbrot DB: Radiosurgery for brain metastases: A score index for predicting prognosis.
    13. (2005). DW: Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery
    14. (2003). EC: Selection of patients with melanoma brain metastases for aggressive treatment.
    15. (2007). Fogaroli RC: Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    16. (2008). Fuller A: Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.
    17. (2005). Gamma knife surgery for the treatment of intracranial metastases from breast cancer.
    18. (2006). Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy.
    19. (2000). GH: Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    20. (2002). GH: Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study.
    21. (2008). GH: Stereotactic radiosurgical treatment of brain metastases in older patients. Cancer
    22. (2002). GH: Survival by Radiation Therapy Oncology Group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma. Cancer
    23. (2008). Gutin PH: Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol
    24. (2008). Henson JW: Survival in patients with brain metastases from breast cancer. Cancer
    25. (2005). Hong JH: Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer.
    26. (1999). Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
    27. (1994). Inoue T: Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol
    28. (2006). Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors. Radiat Oncol
    29. (2006). Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer – A retrospective analysis. Radiother Oncol
    30. (2007). JC: Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery. Technol Cancer Res Treat
    31. (1999). JC: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.
    32. (2004). JF: Determinants of outcome in melanoma patients with cerebral metastases.
    33. (2005). JH: Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors.
    34. (2001). JL: Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors.
    35. (2005). JS: Survival after brain metastases from breast cancer in the trastuzumab era.
    36. (2004). KJ: A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma.
    37. (2006). Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA
    38. (2003). L: Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases. Gynecol Oncol
    39. (2007). Labib A: Brain metastases from breast carcinoma: validation of the Radiation Therapy Oncology Group recursive partitioning analysis classification and proposition of a new prognostic score.
    40. (2005). Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases.
    41. (2005). Lymphopenia: A new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Radiother Oncol
    42. (2005). Mehta MP: Current management of brain metastases, with a focus on systemic options.
    43. (2003). Metastasis of esophageal carcinoma to the brain. Cancer
    44. (2000). Movsas B: Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys
    45. (2006). MP: Whole-brain radiotherapy in the management of brain metastasis.
    46. (2002). Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3. Radiother Oncol
    47. (1996). PG: Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol)
    48. (2008). Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes? Cancer Chemother Pharmacol
    49. (1998). Prognostic factors derived from recursive partitioning analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases.
    50. (2004). Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution. Strahlenther Onkol
    51. (2000). Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys
    52. (2003). Puduvalli VK: Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience. Cancer
    53. (2001). Raaymakers E: Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation. Lung Cancer
    54. (2004). Radiosurgery for treatment of brain metastases: Estimation of patient eligibility using three stratification systems.
    55. (2009). Renschler MF: Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    56. (2005). Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Acta Oncol
    57. (2008). Rugo HS: Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival.
    58. (2006). Salvajoli JV: Whole brain radiation therapy in management of brain metastasis: results and prognostic factors. Radiat Oncol
    59. (2007). SE: A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer
    60. (2008). SE: A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol
    61. (2001). Soffietti R: Brain metastases from unknown primary tumour: a prospective study.
    62. (2003). Suh JH: Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective review. Technol Cancer Res Treat
    63. (2006). Suh JH: RPA classification has prognostic significance for surgically resected single brain metastasis.
    64. (2007). Suh JH: Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
    65. (2007). Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression.
    66. (2006). Tattersall MH: Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer
    67. (2007). The role of postoperative radiotherapy after resection of a single brain metastasis: combined analysis of 643 patients. Strahlenther Onkol
    68. (2006). The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer.
    69. (2007). Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer
    70. (2008). Validation of the graded prognostic assessment index for patients with brain metastases: in regards to Sperduto et al.
    71. (2008). Validation of the graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res
    72. (2000). Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.
    73. (2003). Vogelbaum MA: Posterior fossa metastases: aggressive treatment improves survival. Stereotact Funct Neurosurg
    74. (2004). W e i n b e r g J , S a w a y a R , M a o r M H : Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    75. (1994). Wattendorf AR: The choice of treatment of single brain metastasis should be based on extracranial tumor activity.
    76. (2007). Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). Strahlenther Onkol
    77. (2007). Woo SY: Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.